Results 211 to 220 of about 527,321 (295)

A universal brown dwarf desert formed between planets and stars. [PDF]

Proc Natl Acad Sci U S A
Cui K, Xiao GY, Feng F, Liu B, Nayakshin S, Hall C, Guo K, Lai D, Ogihara M, Rui Y, Boss AP, Butler RP, Xuan Y.   +12 more
europepmc   +1 more source

A CONGRUENCE BETWEEN SYMMETRIC MULTIPLE ZETA-STAR VALUES AND MULTIPLE ZETA-STAR VALUES

A CONGRUENCE BETWEEN SYMMETRIC MULTIPLE ZETA-STAR VALUES AND MULTIPLE ZETA-STAR VALUES
We prove a congruence between symmetric multiple zeta-star values and multiple zeta-star values. This congruence together with Aoki and Ohno's relation, the sum formula and the generalized height-one duality for multiple zeta-star values directly lead to those for the symmetric counterparts.
openaire  

NKCC1: A key regulator of glioblastoma progression

Molecular Oncology, EarlyView.
Glioblastoma (GBM) progression is driven by disrupted chloride cotransporter homeostasis. NKCC1 is highly expressed in stem‐like, astrocytic, and progenitor cells, correlating with earlier recurrence, while overall survival remains unaffected. NKCC1 serves as a prognostic marker and potential therapeutic target, linking chloride transporter imbalance ...
Anja Thomsen, Diana Freitag, Madlen Haase, Christian Senft, Falko Schwarz, Silke Keiner   +5 more
wiley   +1 more source

Genome-wide identification of the histone gene family in foxtail millet (Setaria italica) and analysis of its expression pattern in response to abiotic stress. [PDF]

BMC Plant Biol
Shi W, Ma M, Cheng Y, Cao Y, Yan Z, Qiao X, Liu W.   +6 more
europepmc   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Moderate nutritional stress reprogrammes insulin responses to drive enhanced starvation tolerance in Drosophila melanogaster. [PDF]

J Exp Biol
Menon RV, Varghese J.
europepmc   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Aluminium MOF as a selective sensor for atrazine with docking and computational insight. [PDF]

RSC Adv
Singh S, Varshney R, N P, Uppara B, Ramamurthy PC, Shehata N.   +5 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Incident Heart Failure Risk Following COVID-19 Recovery: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Mihai AM, Marc M, Lucaciu F, Sima A.
europepmc   +1 more source